AdvanSix (NYSE:ASIX) Receives Buy Rating from Stifel Nicolaus

AdvanSix (NYSE:ASIX)‘s stock had its “buy” rating reaffirmed by stock analysts at Stifel Nicolaus in a research note issued to investors on Tuesday, Benzinga reports. They currently have a $40.00 target price on the stock. Stifel Nicolaus’ price target would suggest a potential upside of 42.91% from the stock’s previous close.

AdvanSix Price Performance

ASIX stock opened at $27.99 on Tuesday. AdvanSix has a 52-week low of $23.92 and a 52-week high of $41.11. The stock’s fifty day simple moving average is $26.95 and its 200-day simple moving average is $27.48. The company has a quick ratio of 0.58, a current ratio of 1.17 and a debt-to-equity ratio of 0.23. The stock has a market capitalization of $747.33 million, a price-to-earnings ratio of 14.73 and a beta of 1.73.

AdvanSix (NYSE:ASIX) last issued its earnings results on Friday, February 16th. The company reported ($0.17) earnings per share for the quarter, topping the consensus estimate of ($0.19) by $0.02. The business had revenue of $382.21 million for the quarter, compared to analyst estimates of $335.80 million. AdvanSix had a return on equity of 6.98% and a net margin of 3.56%. Equities research analysts expect that AdvanSix will post 0.94 EPS for the current year.

Insider Buying and Selling

In related news, SVP Achilles B. Kintiroglou sold 4,000 shares of the stock in a transaction on Monday, April 1st. The stock was sold at an average price of $27.69, for a total value of $110,760.00. Following the transaction, the senior vice president now directly owns 38,996 shares of the company’s stock, valued at approximately $1,079,799.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other AdvanSix news, SVP Achilles B. Kintiroglou sold 4,000 shares of the firm’s stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $27.69, for a total value of $110,760.00. Following the transaction, the senior vice president now directly owns 38,996 shares of the company’s stock, valued at $1,079,799.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Erin N. Kane sold 1,385 shares of the firm’s stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $27.96, for a total value of $38,724.60. Following the completion of the transaction, the chief executive officer now directly owns 556,370 shares in the company, valued at $15,556,105.20. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 17,387 shares of company stock valued at $486,481. 5.20% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Copeland Capital Management LLC purchased a new position in AdvanSix in the fourth quarter valued at about $27,000. Point72 Hong Kong Ltd purchased a new stake in shares of AdvanSix during the first quarter worth about $32,000. Tower Research Capital LLC TRC increased its position in shares of AdvanSix by 68.2% during the second quarter. Tower Research Capital LLC TRC now owns 1,189 shares of the company’s stock worth $42,000 after acquiring an additional 482 shares during the last quarter. Osaic Holdings Inc. increased its position in shares of AdvanSix by 20.6% during the second quarter. Osaic Holdings Inc. now owns 4,164 shares of the company’s stock worth $116,000 after acquiring an additional 710 shares during the last quarter. Finally, Captrust Financial Advisors increased its position in shares of AdvanSix by 30.1% during the first quarter. Captrust Financial Advisors now owns 2,656 shares of the company’s stock worth $136,000 after acquiring an additional 614 shares during the last quarter. 86.39% of the stock is owned by hedge funds and other institutional investors.

About AdvanSix

AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.